Novel oxazole derivatives, their manufacture and use as pharmaceutical agents

Details for Australian Patent Application No. 2004224173 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Bossenmaier, Birgit; Friess, Thomas; Voss, Edgar; Friebe, Walter-Gunar; Goller, Bernhard; Rueth, Matthias

Agent Davies Collison Cave

Pub. Number AU-A-2004224173

PCT Pub. Number WO2004/085434

Priority 03007124.5 28.03.03 EP; 60/459,741 02.04.03 US

Filing date 26 March 2004

Wipo publication date 7 October 2004

International Classifications

C07D 413/12 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61K 031/422 - not condensed and containing further heterocyclic rings

C07D 413/14 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61P 035/00 Antineoplastic agents

Event Publications

20 October 2005 PCT application entered the National Phase

  PCT publication WO2004/085434 Priority application(s): WO2004/085434

22 October 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004224177-Synthesis of 2-chloromethyl-6-methylbenzoic acid esters

2004224171-Aminotriazine condensation product, use of an aminotriazine condensation product and method for the production of an aminotriazine condensation product